Kyulux Raises $53.7M Series D Round

Quadlytics Inc.

Quadlytics is building AI-powered technology to address one of the most difficult challenges in epilepsy care: seizure unpredictability. Our platform combines wearable sensing and machine learning to detect anomalous physiological changes from wearable data and provide timely insights for patients and caregivers, while supporting clinicians with relevant data for care discussions. By enabling earlier preparation and more informed decision-making, we aim to support a new model of proactive epilepsy care and help people with epilepsy live with greater confidence and independence. Our technology is currently under development and not yet available for clinical use.

BionicM

At BionicM, we are powering mobility through innovation. Founded in 2018 as a spin-off from the University of Tokyo, we specialize in creating cutting-edge powered prosthetic solutions that enhance independence and improve the quality of life for lower-limb amputees. Our flagship product, the Bio Leg®, is a powered prosthetic knee that leverages advanced robotics to replicate lost muscle strength, enabling natural, intuitive movement. With FDA approval and U.S. medical insurance coverage, the Bio Leg® is transforming lives by reducing physical strain and empowering users to lead active, fulfilling lifestyles. With our new U.S. subsidiary, headquartered in the Washington, D.C. area, we are accelerating our efforts to bring innovative prosthetic solutions to the world’s largest prosthetics market. Recognized as a CES Innovation Awards® 2025 Best of Innovation honoree, BionicM continues to lead the way in the convergence of robotics and healthcare. We are committed to empowering mobility for all, combining cutting-edge technology with human-centric design to make a meaningful impact.